Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment

Antoine Abou Rached1 Faculty of Medicine, School of Medicine, Lebanese University, Beirut, Lebanon, [email protected]Correspondence[email protected]

Selim Abou Kheir1 Faculty of Medicine, School of Medicine, Lebanese University, Beirut, Lebanon, [email protected]

Jowana Saba1 Faculty of Medicine, School of Medicine, Lebanese University, Beirut, Lebanon, [email protected]

Salwa Assaf2 Abbvie Biopharmaceuticals GmbH, Beirut, Lebanon

Georges Kassis3 Abbvie Biopharmaceuticals, Paris, France

Yuri Sanchez Gonzalez4 AbbVie Inc., North Chicago, IL, USA

Olivier Ethgen5 SERFAN Innovation, Namur, Belgium;6 Department of Public Health, Epidemiology and Health Economics, University de Liège, Liège, Belgium

show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date